AAAAAA

   
Results: 1-8 |
Results: 8
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumorgrowth and angiogenesis: Possible role of the vascular endothelial growth factor
Authors: Yoshiji, H Kuriyama, S Kawata, M Yoshii, J Ikenaka, Y Noguchi, R Nakatani, T Tsujinoue, H Fukui, H
Citation: H. Yoshiji et al., The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumorgrowth and angiogenesis: Possible role of the vascular endothelial growth factor, CLIN CANC R, 7(4), 2001, pp. 1073-1078
Angiotensin-II type I receptor interaction is a major regulator for liver fibrosis development in rats
Authors: Yoshiji, H Kuriyama, S Yoshii, J Ikenaka, Y Noguchi, R Nakatani, T Tsujinoue, H Fukui, H
Citation: H. Yoshiji et al., Angiotensin-II type I receptor interaction is a major regulator for liver fibrosis development in rats, HEPATOLOGY, 34(4), 2001, pp. 745-750
The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model
Authors: Yoshiji, H Kuriyama, S Hicklin, DJ Huber, J Yoshii, J Ikenaka, Y Noguchi, R Nakatani, T Tsujinoue, H Fukui, H
Citation: H. Yoshiji et al., The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model, HEPATOLOGY, 33(4), 2001, pp. 841-847
BodyMap: A collection of 3 ' ESTs for analysis of human gene expression information
Authors: Kawamoto, S Yoshii, J Mizuno, K Ito, K Miyamoto, Y Ohnishi, T Matoba, R Hori, N Matsumoto, Y Okumura, T Nakao, Y Yoshii, H Arimoto, J Ohashi, H Nakanishi, H Ohno, I Hashimoto, J Shimizu, K Maeda, K Kuriyama, H Nishida, K Shimizu-Matsumoto, A Adachi, W Ito, R Kawasaki, S Chae, KS Murakawa, K Yokoyama, M Fukushima, A Hishiki, T Nakaya, A Sese, J Monma, N Nikaido, H Morishita, S Matsubara, K Okubo, K
Citation: S. Kawamoto et al., BodyMap: A collection of 3 ' ESTs for analysis of human gene expression information, GENOME RES, 10(11), 2000, pp. 1817-1827
Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model
Authors: Yoshiji, H Kuriyama, S Miyamoto, Y Thorgeirsson, UP Gomez, DE Kawata, M Yoshii, J Ikenaka, Y Noguchi, R Tsujinoue, H Nakatani, T Thorgeirsson, SS Fukui, H
Citation: H. Yoshiji et al., Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model, HEPATOLOGY, 32(6), 2000, pp. 1248-1254
KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
Authors: Yoshiji, H Kuriyama, S Hicklin, DJ Huber, J Yoshii, J Miyamoto, Y Kawata, M Ikenaka, Y Nakatani, T Tsujinoue, H Fukui, H
Citation: H. Yoshiji et al., KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells, HEPATOLOGY, 30(5), 1999, pp. 1179-1186
Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis
Authors: Yoshiji, H Kuriyama, S Ways, DK Yoshii, J Miyamoto, Y Kawata, M Ikenaka, Y Tsujinoue, H Nakatani, T Shibuya, M Fukui, H
Citation: H. Yoshiji et al., Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis, CANCER RES, 59(17), 1999, pp. 4413-4418
Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells
Authors: Yoshiji, H Kuriyama, S Yoshii, J Yamazaki, M Kikukawa, M Tsujinoue, H Nakatani, T Fukui, H
Citation: H. Yoshiji et al., Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells, HEPATOLOGY, 28(6), 1998, pp. 1489-1496
Risultati: 1-8 |